Consensus Haemonetics Corporation

Equities

HAE

US4050241003

Market Closed - Nyse Other stock markets 01:30:02 27/04/2024 am IST			5-day change	1st Jan Change
90.99 ^USD	+3.80%		+12.00%	+6.41%

04/04	Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge	MT
04/04	Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge	CI

Evolution of the average Target Price on Haemonetics Corporation

Price target over the last 5 years

History of analyst recommendation changes

5354f10c58639ab92ccb2c464fb3d.HN43pf8GXKnaxYckoUrtMIClno5U1WQlTtv7zDYg4j0.ba9CnchUGuuMvPdg1yaIXMTNzsUj5A5xe7POlAYUz2dy51CSrXYznumTvw~f2cc5214a8410a172e62102f165df627

Analyst Recommendations on Haemonetics Corporation

Barrington Cuts Price Target on Haemonetics to $105 From $114 on 'Macro Concerns', Keeps Outperform Rating	03/11	MT
Citigroup Raises Haemonetics' Price Target to $94 From $90, Keeps Neutral Rating	02/23/02	MT
Barrington Raises Price Target on Haemonetics to $114 From $111, Keeps Outperform Rating	09/23/09	MT
Morgan Stanley Adjusts Price Target on Haemonetics to $96 From $88, Maintains Equal-Weight Rating	12/23/12	MT
Barrington Ups Price Target on Haemonetics to $111 From $103, Keeps Outperform Rating	12/23/12	MT
JMP Securities Adjusts Price Target on Haemonetics to $115 From $105, Maintains Market Outperform Rating	12/23/12	MT
Morgan Stanley Raises Haemonetics' Price Target to $88 From $84, Maintains Equalweight Rating	08/23/08	MT
Mizuho Securities Adjusts Price Target on Haemonetics to $115 From $110, Maintains Buy Rating	08/23/08	MT
Citigroup Raises Haemonetics' Price Target to $95 From $92, Maintains Neutral Rating	08/23/08	MT
Barrington Research Raises Haemonetics' Price Target to $103 From $94, Maintains Outperform Rating	08/23/08	MT
Mizuho Adjusts Haemonetics' Price Target to $110 From $100, Keeps Buy Rating	24/23/24	MT
Morgan Stanley Cuts Price Target on Haemonetics to $84 From $90, Reiterates Equalweight Rating	06/23/06	MT
Citigroup Boosts Price Target on Haemonetics to $92 From $88, Affirms Neutral Rating	12/22/12	MT
Citigroup Adjusts Price Target on Haemonetics to $88 From $80, Maintains Neutral Rating	08/22/08	MT
Barrington Hikes Price Target for Haemonetics to $94 From $88, Keeps Outperform Rating	08/22/08	MT
Morgan Stanley Adjusts Price Target on Haemonetics to $90 From $85, Maintains Equalweight Rating	08/22/08	MT
Raymond James Adjusts Price Target on Haemonetics to $100 From $88, Maintains Outperform Rating	08/22/08	MT
JMP Securities Adjusts Price Target on Haemonetics to $105 From $90, Maintains Market Outperform Rating	08/22/08	MT
Mizuho Adjusts Price Target on Haemonetics to $100 From $90, Maintains Buy Rating	08/22/08	MT
Mizuho Securities Starts Haemonetics at Buy With $90 Price Target	13/22/13	MT
Morgan Stanley Adjusts Haemonetics' Price Target to $85 from $74, Maintains Equalweight Rating	11/22/11	MT
Morgan Stanley Adjusts Haemonetics' Price Target to $74 From $70, Keeps Equalweight Rating	11/22/11	MT
Barrington Research Adjusts Haemonetics' Price Target to $88 from $77, Keeps Outperform Rating	11/22/11	MT
JMP Securities Adjusts Haemonetics Price Target to $90 From $80, Maintains Market Outperform Rating	11/22/11	MT
Raymond James Adjusts Haemonetics' Price Target to $88 from $76, Maintains Outperform Rating	11/22/11	MT